| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/10/2004 | EP1198453B9 N-(indolcarbonyl-)piperazin derivatives |
| 11/10/2004 | EP1187854B1 Per(3,6-anhydro)cyclodextrin derivatives, preparation and use thereof for separating ions |
| 11/10/2004 | EP1161423B1 Thiazolyl urea derivatives and their utilization as antiviral agents |
| 11/10/2004 | EP1161246B1 Use of certain dinucleotidetriphosphate, cytidinediphosphate and adeninediphosphate for preparing a pharmaceutical composition for stimulating mucosal hydration |
| 11/10/2004 | EP1159258B1 Amide compounds for the potentiation of cholinergic activity |
| 11/10/2004 | EP1156799A4 Method for treating copd |
| 11/10/2004 | EP1144389B1 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salt |
| 11/10/2004 | EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 11/10/2004 | EP1131050B8 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 11/10/2004 | EP1117408B9 Use of diltiazem for treating retinal pathologies |
| 11/10/2004 | EP1107750B1 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 11/10/2004 | EP1104415B1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 11/10/2004 | EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 11/10/2004 | EP1061901B1 Nicotine inhaler |
| 11/10/2004 | EP1045700B1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 11/10/2004 | EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents |
| 11/10/2004 | EP1017384B1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 11/10/2004 | EP0975348B1 Stabilized tibolone compositions |
| 11/10/2004 | EP0958821B1 Fat emulsion containing xanthine derivative |
| 11/10/2004 | EP0935460B1 Taste masked pharmaceutical compositions |
| 11/10/2004 | EP0929544B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 11/10/2004 | EP0790056B1 Use of composition for preventing or treating diseases caused by abnormalities in cartilage tissues |
| 11/10/2004 | EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE |
| 11/10/2004 | CN1545557A Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 11/10/2004 | CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 11/10/2004 | CN1545522A Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 11/10/2004 | CN1545515A 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative |
| 11/10/2004 | CN1545513A Novel 2H -pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 11/10/2004 | CN1545512A Rapamycin dialdehydes |
| 11/10/2004 | CN1545511A Rapamycin 29-enols |
| 11/10/2004 | CN1545510A Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 11/10/2004 | CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity |
| 11/10/2004 | CN1545508A 1,2,4-trioxolane antimalarials |
| 11/10/2004 | CN1545505A Polymorph salt of a pyridazinone derivative for the treatment of arrythmia |
| 11/10/2004 | CN1545500A Carbonyloxy-cyanomethyl compounds as antiparasitic agents |
| 11/10/2004 | CN1545428A Treatment for ocular infections |
| 11/10/2004 | CN1545421A Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 11/10/2004 | CN1545419A Antineoplastic combinations |
| 11/10/2004 | CN1545418A Method of increasing the presence of glutathione in cells |
| 11/10/2004 | CN1545415A Bone anabolic compounds and methods of use |
| 11/10/2004 | CN1545414A Organic compounds |
| 11/10/2004 | CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
| 11/10/2004 | CN1545412A Preventive agent/remedial agent for constipation predominant ibs |
| 11/10/2004 | CN1545411A Cyclopropyl and cyclobutyl epothilone analogs |
| 11/10/2004 | CN1545410A Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions |
| 11/10/2004 | CN1545409A Use of stilbene compounds in preparing medicaments for treating and preventing diabetes or diseases associated with retrovirus |
| 11/10/2004 | CN1545408A Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
| 11/10/2004 | CN1545407A Transdermal therapeutic system (TTS) with fentanyl as active ingredient |
| 11/10/2004 | CN1545406A Water-free ubichinon concentrate |
| 11/10/2004 | CN1545383A Animal feed with low PUFA concentration |
| 11/10/2004 | CN1544945A Inhibition of Tau-Tau-association |
| 11/10/2004 | CN1544596A Male sexual function lotion and preparing process thereof |
| 11/10/2004 | CN1544478A Pearl oyster monomer polysaccharide ZBP-I and extraction method and uses in preparation of drugs for tumor |
| 11/10/2004 | CN1544477A Urushi polysaccharide sulfation and its preparation method and uses |
| 11/10/2004 | CN1544475A Sulfated Polyguluronic Acid Ester and its preparation method and uses |
| 11/10/2004 | CN1544465A Protein for promoting nerve differentiation and resisting cell death, and its coding gene |
| 11/10/2004 | CN1544454A Antisense nucleic acid for multiple drug resistance gene of human epidermis tumor cell |
| 11/10/2004 | CN1544452A Novel macrolides drug 4'-epitope-9alfa-N-R-9alfa-aza homoerythromycin A derivative, synthesis method and uses |
| 11/10/2004 | CN1544451A Novel macrolides drug -9-OR-erythromycin A oxime, synthesis method and uses |
| 11/10/2004 | CN1544450A Novel macrolides drug 9-deoxidized-9alfa-N-substituted alkane or amide- erythromycin A derivative, synthesis method and uses |
| 11/10/2004 | CN1544442A 3,6-double(3-methyl pyridine-2yl)-S-tetrazine and transition metal complex, and its preparation and uses |
| 11/10/2004 | CN1544433A Extracting and separating method of novel langdu root essence B from stellera chamaejasme L and its uses |
| 11/10/2004 | CN1544429A Bee glue flavone extract preparation method, pharmaceutical preparation and its new medical uses |
| 11/10/2004 | CN1544425A Daphnetin derivative |
| 11/10/2004 | CN1544423A Anti-tumour effective constituent cherimoya essence preparation method |
| 11/10/2004 | CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas |
| 11/10/2004 | CN1544418A N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity |
| 11/10/2004 | CN1544092A Ophthalmic compositions containing galactomannan polymers and borate |
| 11/10/2004 | CN1544088A Immediate release tablet |
| 11/10/2004 | CN1544085A Reproduction rate increasing preparation and its making method for cow and ewe |
| 11/10/2004 | CN1544068A Antigout medicinal composition and its preparing method |
| 11/10/2004 | CN1544011A Application of flatstem milkvetch seed and its extract in the preparation of anti hepatic fibrosis medicine and anticancer medicine |
| 11/10/2004 | CN1543984A Strontium-calcium composite tonic series and its preparation |
| 11/10/2004 | CN1543983A Wound nursing medicinal composition |
| 11/10/2004 | CN1543982A Chitose antibacterial film of uterine neck |
| 11/10/2004 | CN1543981A Anti-adhesion drug composition and its preparation and application |
| 11/10/2004 | CN1543980A Mohailin dripping pills and its preparation |
| 11/10/2004 | CN1543979A Preparing process of anticoagulant konjak glucomanan sulfate |
| 11/10/2004 | CN1543978A Highly concentration water-soluble vitamin for intravenous injection and preparation and use |
| 11/10/2004 | CN1543977A Medicine for treating cerebrovascular and cardiovascular diseases and preparation process thereof |
| 11/10/2004 | CN1543976A Astragaloside injection preparation and its preparing process |
| 11/10/2004 | CN1543975A Powder injection of hawthorn leaf flavonid salt and its preparation |
| 11/10/2004 | CN1543974A Notoginsen triterpenes liposome and prepartion thereof |
| 11/10/2004 | CN1543973A Highly effective sustained release breviscapine compositions and its granule capsule |
| 11/10/2004 | CN1543972A Adriamycin ultrafine fibre preparation and method for making the same |
| 11/10/2004 | CN1543971A Oral disintegrating tablet and its preparation of compound red sage root |
| 11/10/2004 | CN1543970A Compositions of asiatic centella and Hypericum perforatum extracts and its antidepressant action |
| 11/10/2004 | CN1543969A Application of Japanese raspberry saponin in the treatment of cerebral ischemia disease |
| 11/10/2004 | CN1543968A Drug prepared by mulberry bark extract |
| 11/10/2004 | CN1543967A Benproperine phosphate dripping pills and preparation |
| 11/10/2004 | CN1543966A Oral powder preparation for treating cirrhosis ascites |
| 11/10/2004 | CN1543965A Cucurbitacin dripping pills and preparation technique |
| 11/10/2004 | CN1543964A Application in antidepressants preparation of asiatic acid and derivation |
| 11/10/2004 | CN1543963A Use of 2ª‡,23-dihydroxyl ursolic acid in preparing the anti-inflammatory agent |
| 11/10/2004 | CN1543962A Novel medical use of 2ª‡,23- dihydroxyl ursolic acid |
| 11/10/2004 | CN1543961A Oxazepam dripping pills and preparation thereof |
| 11/10/2004 | CN1543960A Imipramine hydrochloride dripping pills and preparation |
| 11/10/2004 | CN1543959A Galantamin sustained release preparation and preparing process |
| 11/10/2004 | CN1543958A Antibiotic action enhancing medicinal composition |
| 11/10/2004 | CN1543957A Penciclovir gelling agent and its prepartion |